Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by stockmonster6on Dec 12, 2020 2:05pm
133 Views
Post# 32093690

RE:RE:RE:CAN SOMEONE..

RE:RE:RE:CAN SOMEONE..I am not sure why people are assuming there will be a NR so rapidly.

They are proceeding with the 300 person study, as per the HC policy. They said this may take up to the end of the year, or perhaps early January.  They are also engaging in the asymptomatic study, but they didn't say when.  Wouldn't make sense to do that until AFTER the 300 person study is done that will refine the sensitivity.

Once studies are done, HC takes 45 says to do their own analysis.  This leads us to potentially early to mid Feb.

I can see a NR, mid to late Jan re: the results of the study and sensitivity.
I can see a NR shortly after that, within a week or so, indicating the application to HC has been received.  After that, at least 45 days (unless HC decides to super fast track it).

There could potentially be another NR around the same time as the HC application is they apply to the FDA concurrently.

It would be wise for people to actually read the NR, and do a bit of DD on Health Canada's site; however, I did post all those links on the day the NR was released for everyone's edification.

Those are my timelines, and I believe reasonable.

I will of course, be certainly happy if THRM exceeds it.

those who are waiting, don't wait too long.  THRM will only be increasing.  Many missed the 7 cent boat - now it's 22 cents.
<< Previous
Bullboard Posts
Next >>